This grant funds early-career faculty conducting translational medicine research that bridges lab discoveries with clinical applications, emphasizing human-relevant validation and clinical collaboration.
Funder: PhRMA Foundation
Due Dates: May 27, 2026: Letter of Intent deadline (LOI) | November 18, 2026: Full application deadline (by invitation)
Funding Amounts: $100,000 for one year; funds must be used for research expenses (not PI salary or indirect costs).
Summary: Supports early-career faculty in translational medicine research that bridges laboratory discoveries and clinical applications, with a focus on human-relevant validation and clinical collaboration.
Key Information: Two-stage application (LOI, then full application by invitation); strict eligibility criteria regarding faculty start date and prior funding.
The PhRMA Foundation Faculty Starter Grant in Translational Medicine provides $100,000 in research support for early-career faculty at accredited U.S. universities. The program aims to accelerate the translation of basic scientific discoveries into clinical practice by supporting innovative research addressing unmet clinical needs. Projects should develop or validate diagnostic, therapeutic, or computational approaches, with a strong emphasis on human or human-relevant systems and clinical collaboration. Proposals must be hypothesis-driven and include a clear plan for translational validation in human contexts. Studies that are purely descriptive, lack a therapeutically relevant hypothesis, or rely solely on animal models without a human component are not eligible.